These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18230140)

  • 1. From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.
    Sipilanyambe N; Simon JL; Chanda P; Olumese P; Snow RW; Hamer DH
    Malar J; 2008 Jan; 7():25. PubMed ID: 18230140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.
    Zurovac D; Ndhlovu M; Rowe AK; Hamer DH; Thea DM; Snow RW
    BMJ; 2005 Oct; 331(7519):734. PubMed ID: 16195289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
    Amin AA; Zurovac D; Kangwana BB; Greenfield J; Otieno DN; Akhwale WS; Snow RW
    Malar J; 2007 May; 6():72. PubMed ID: 17535417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
    Zurovac D; Ndhlovu M; Sipilanyambe N; Chanda P; Hamer DH; Simon JL; Snow RW
    Malar J; 2007 Mar; 6():31. PubMed ID: 17367518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From chloroquine to artemisinin-based combination therapy: the Sudanese experience.
    Malik EM; Mohamed TA; Elmardi KA; Mowien RM; Elhassan AH; Elamin SB; Mannan AA; Ahmed ES
    Malar J; 2006 Jul; 5():65. PubMed ID: 16879742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.
    Tarimo DS; Malekela DA
    East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia.
    Barnes KI; Chanda P; Ab Barnabas G
    Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S8. PubMed ID: 19818175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
    Mwendera C; de Jager C; Longwe H; Phiri K; Hongoro C; Mutero CM
    Health Res Policy Syst; 2016 Jun; 14(1):41. PubMed ID: 27246503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia.
    Chanda P; Masiye F; Chitah BM; Sipilanyambe N; Hawela M; Banda P; Okorosobo T
    Malar J; 2007 Feb; 6():21. PubMed ID: 17313682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
    Zurovac D; Tibenderana JK; Nankabirwa J; Ssekitooleko J; Njogu JN; Rwakimari JB; Meek S; Talisuna A; Snow RW
    Malar J; 2008 Sep; 7():181. PubMed ID: 18803833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework.
    Mori AT; Kaale EA
    Implement Sci; 2012 Mar; 7():18. PubMed ID: 22423610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.
    Krudsood S; Tangpukdee N; Muangnoicharoen S; Thanachartwet V; Luplertlop N; Srivilairit S; Wilairatana P; Kano S; Ringwald P; Looareesuwan S
    Korean J Parasitol; 2007 Jun; 45(2):111-4. PubMed ID: 17570973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
    Zurovac D; Njogu J; Akhwale W; Hamer DH; Snow RW
    Trop Med Int Health; 2008 Jan; 13(1):99-107. PubMed ID: 18291008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
    Simba D; Kakoko D
    Tanzan J Health Res; 2012 Apr; 14(2):89-95. PubMed ID: 26591729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros].
    Silai R; Moussa M; Abdalli Mari M; Astafieva-Djaza M; Hafidhou M; Oumadi A; Randrianarivelojosia M; Said Ankili A; Said Ahmed B; Gayibor AH; Ariey F; Ringwald P
    Bull Soc Pathol Exot; 2007 Feb; 100(1):6-9. PubMed ID: 17402684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the consent of the patients have a role to play in formulating a treatment policy?
    Kango M; Baboo KS
    Trop Doct; 2008 Jan; 38(1):56-7. PubMed ID: 18302874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.